News & Updates

Making an impact on
the epidemic.

Driven by our passion for combining innovation and science with action, FORE is committed to convening and supporting partners advancing patient-centered, innovative, evidence-based solutions addressing the opioid crisis. Learn more about our activities below or sign up to stay up-to-date on our collective goal of bringing an end to the crisis.

Sign Up for Updates

Webinar: Federal and State Policy Levers to Maintain Access to MOUD March 23, 2020

Due to the tremendous response to our webinar last Thursday, FORE is developing a weekly webinar series to continue to provide information and board support to those on the frontlines maintaining access to opioid use disorder (OUD) treatment and recovery services during the COVID-19 pandemic.

Building off of last week’s successful webinar, please join us as we welcome Jocelyn Guyer, MPA, Managing Director at Manatt Health, and Jodi Manz, MSW, Project Director for Chronic and Vulnerable Populations at the National Academy for State Health Policy (NASHP) for a discussion on emerging federal and state actions and opportunities to assist those with OUD through the COVID-19 pandemic this Thursday, March 26 at 3pm EST. They will review the latest federal and state guidance focused on what can be done to support people with OUD during the response to the pandemic. The presenters will include case studies and concrete examples from states and localities around the country. An open Q&A session will follow the presentation.

View the recorded webinar | Download webinar slides

We continue to invite you to look at our Resources page for the most up-to-date information and guidance. As always, please reach out with questions and/or resources that you believe would benefits others.

Webinar & Resources: MOUD and the COVID-19 National Emergency Response March 17, 2020

Update, 3/19/2020: FORE has posted an Opinion Letter with a legal analysis of four hypothetical scenarios for prescribing buprenorphine for OUD during the COVID-19 public health emergency. You can find it in our Resources section with other updated guidance from Federal agencies. The recorded webinar and slides are also now available for download below.


As the nation rapidly evolves its efforts to contain the coronavirus outbreak, FORE has been in contact with our grantees and others on the frontlines in an effort to identify the most pressing challenges in maintaining access to opioid use disorder (OUD) treatment and recovery services. We hope that by generating this information, and helping to identify solutions, we can provide some broad assistance during a time of such uncertainty.

We will be using our website and LinkedIn page to draw attention to unmet needs and the strategies that health care organizations, government agencies, and community-based organizations are using to confront them.

We invite you to look at our Resources page for valuable information — including recently produced guidance from our California Bridge grantee at the Public Health Institute. This guidance outlines strategies for serving OUD patients who face serious risks pursuing face-to-face care during this pandemic.

Working with FORE, Dr. Hannah Snyder, Co-Principal Investigator of CA Bridge, will conduct a national webinar this Thursday, March 19 at 3pm EST. The webinar will highlight their guidance on how we can think creatively about using telemedicine and other tools to reduce barriers to access and ensure support is available to those in recovery as in-person meetings are temporarily limited. In addition, we will be joined by Jodi Manz, MSW, Project Director for Chronic and Vulnerable Populations at the National Academy for State Health Policy (NASHP) and Daniel McClughen, Esq., Associate at DCBA Law & Policy, to answer your questions concerning evolving regulations and newly issued guidance around MOUD during the pandemic.

View the recorded webinar | Download webinar slides

If you have not seen it already, we also highly recommend a recent post on the blog of Nora Volkow, M.D., Director of the National Institute on Drug Abuse, which highlights the added risks populations with substance use disorder face. Additionally, new SAMHSA guidance for opioid treatment programs was released yesterday.

We will be working with partners to continue to develop and share information in response to pressing questions related to maintaining access to treatment during this time. Please reach out with questions and/or resources that would benefit others so we can share them.

$10.1 Million in Grants to Improve Access to Opioid Use Disorder Treatment March 12, 2020

Today, FORE announced its first round of grant awards. We are proud to support 19 organizations that are working to increase access to opioid use disorder treatment in diverse and innovative ways. They demonstrate an array of models of working on the frontlines to end the opioid crisis.

These 19 projects were selected from a highly competitive field of more than 400 applicants; the selection process was informed by reviews from 50 independent experts. Our grantees will be working to expand access to treatment for vulnerable populations, including pregnant women, the homeless, and those just released from jails or prisons who are at high risk of relapse and overdose deaths. From remote areas of Alaska and Alabama to New Hampshire and New York City, they are working to engage and educate health care providers and fielding peer support workers and doulas to forge relationships that lead to lasting recovery.

Others are helping to develop and spread new care models that leverage telemedicine to reach patients in remote, underserved areas or build capacity in emergency departments, which can play a vital role in initiating treatment and routing patients to ongoing care. Still others are doing the important work of identifying what’s most effective and why, generating insights for policymakers and payers.

As a group they are promoting access to opioid use disorder treatment across the U.S., with a particular focus on urban, rural, minority, tribal, and low-income communities that lack resources to meet patients and families’ needs. Visit Our Grantees page to learn more about these organizations and their plans for spreading innovative, evidence-based solutions to the crisis.

As we support our grantees in achieving their goals, we will be looking to fund additional work as part of a comprehensive approach that includes educating professionals about opioid use disorder prevention and treatment; developing sustainable payment approaches; informing state and federal policies to ensure access to care; and raising public awareness of effective strategies to end the crisis.

Download: Full Press Release | Media Kit

President’s Update, Feb. ’20: Being Guided by Experts February 26, 2020

The leadership of the Foundation for Opioid Response Efforts (FORE) is dedicated to deploying our resources in the most impactful way. To do so, we convened four advisory meetings over the past several months, with the aim of understanding the range of existing approaches to opioid use disorder (OUD) prevention and treatment and how we might contribute through grantmaking, convenings, partnerships, and information dissemination.

The program advisory meetings were also an opportunity to seek guidance on areas of work FORE should avoid — either because they duplicate other efforts, have too narrow a focus, or are unlikely to have an impact. Engaging experts in state and federal policy, addiction medicine and primary care, pharmacy, criminal justice, health insurance, rural health, veterans’ health, women’s health, and other fields informed our first request for proposals on access to treatment, as well as the selection of our inaugural grants, which will be announced shortly.

In the meantime, we wanted to share summaries of the discussions and recommendations of our experts. The following three summaries are now available in our new Resources section of our website:

A fourth summary, on Improving Clinical Practice of Pain Management, will be available soon.

Our first advisory meeting, which focused on access to treatment, offered a sobering account of the challenge: only one of nine people coping with a substance use disorder receives treatment. As with other parts of our health care system, there are racial, economic, and geographic disparities in who gets treatment, with certain groups — including minorities and those involved in the criminal justice system — at particular risk. Poor access to effective treatment equates to higher mortality. Participants also noted that many people coping with OUD need more than medical treatment to rebuild their lives, including counseling and wraparound supports.

In June, we heard from experts about ways to train and equip the next generation of clinicians to help prevent, identify, and treat opioid addiction. Experts emphasized the importance of giving medical students and residents opportunities to see the effectiveness of OUD treatment firsthand in hopes of reducing bias against what some may see as “difficult” patients. They also called for development of new models that bring clinical specialties together and foster interdisciplinary training so that students of the health professions — including physicians, nurses, social workers, pharmacists, dentists, and others — learn to work as a team to provide care.

During our July advisory meeting, we explored health care delivery and payment reforms that may help expand access to OUD treatment. The group considered innovative models such as Vermont’s hub-and-spoke approach, in which specialized drug treatment centers treat the most clinically complex patients are connected with  primary care practices who are supported to be able to treat those with less complex needs. Others pointed to the health home model, which has been used to offer coordinated physical and behavioral health care for people with multiple chronic conditions, including mental health and substance use disorders. Participants suggested that peer support coaches and telehealth tools could help engage more people in treatment. Expansion of the clinical workforce, better performance metrics, and new payment policies would be needed to help spread and scale effective treatment models.

Our sincere thanks to the many leaders who contributed their time and expertise to these discussions. We will continue to draw on their suggestions and hold additional advisory meetings as we move forward.

(Picture: Participants in our first advisory meeting on ‘Access to Treatment’ included (from left to right) Mary Wakefield, Ph.D., R.N. (Chair), Elizabeth Connolly, Mishka Terplan, M.D., M.P.H., Kelly J. Clark, M.D., M.B.A., Judge Peggy Fulton Hora (retired), Loretta Finnegan, M.D., Douglas Olson, M.D., Hendree Jones, Ph.D., and Mark Levine, M.D.)

H. Westley Clark, M.D., J.D., M.P.H., Expert in Addiction Treatment and Policy, Joins FORE’s Board of Directors February 6, 2020

We are pleased to welcome H. Westley Clark, M.D., M.P.H., J.D., Dean’s Executive Professor of Public Health at Santa Clara University, to FORE’s board. Clark is a psychiatrist, lawyer, and expert on substance use disorder and treatment, pain management, and psychopharmacology. He also brings a wealth of knowledge about the legal, ethical, and policy issues associated with addiction and behavioral health.

“Dr. Clark knows firsthand what works to help people diagnosed with substance use disorder — and how our policies and regulations can impede or catalyze access to treatment,” says Andrea Barthwell, M.D., FORE’s board chair. “We’re thrilled to have his leadership”.

As director of the Center for Substance Abuse Treatment at the federal Substance Abuse and Mental Health Services Administration (SAMHSA) from 1998 to 2014, Clark led the nation’s effort to make evidence-based addiction treatment more accessible to all Americans. That work informed his contributions to Facing Addiction in America: The Surgeon General’s Report on Alcohol, Drugs, and Health, for which he served as the section editor for treatment in 2016.

He also spent more than a decade providing clinical care to our nation’s veterans, first as the chief of the Substance Abuse Inpatient Unit and later as chief of the Associated Substance Abuse Programs at the Department of Veterans Affairs Medical Center in San Francisco, Calif.

Dr. Clark has been a strong advocate for preserving the privacy protections that prevent the unauthorized disclosure of a patient’s treatment for substance use disorder, which is vital to encouraging people to seek care. “No other medical condition evokes the same societal prejudice or sanctions as addiction,” Dr. Clark wrote in an editorial for STAT. He has also written about the role of trauma in substance use disorder and the importance of integrating other medical services, including hepatitis treatment, into addiction care.

Clark has received several awards, including: the 2015 Lisa Mojer-Torres Award from Faces &Voices of Recovery, the 2015 James Ralph Memorial Award for Outstanding Public Service from the Black Psychiatrists of America, the 2015 Annual Award from the American Society of Addiction Medicine, and the 2008 John P. McGovern Award from the American Society of Addiction Medicine.

Clark earned a B.A. in chemistry from Wayne State University. He earned his M.D. and M.P.H. from the University of Michigan and completed a psychiatric residency at its University Hospital Neuropsychiatric Institute. He also completed a fellowship in addiction psychiatry at San Francisco Veterans Affairs Medical Center. He is board certified in psychiatry with a specialty certification in addiction medicine from the American Board of Preventive Medicine. Dr. Clark earned his J.D. from Harvard University Law School and is a member of the Washington DC Bar.

“I’m honored to be part of FORE’s efforts to increase access to treatment for opioid use disorder and promote innovative solutions to a pressing public health crisis,” Clark says “It’s an opportunity to bring my experience to bear on an issue I care deeply about.”

President’s Update, Dec. ’19: Happy Holidays from FORE! December 23, 2019

As the year comes to a close, and before we usher in a new one, we at FORE wanted to express our gratitude to every person who has advised us, worked with us, and responded to our inaugural request for proposal.

Our first year as an organization has been filled with many positive and inspiring experiences as we worked to build FORE’s infrastructure and programming, and we thank each and every one of you who has helped to fulfill our objectives. We have enjoyed each and every partnership we have had the pleasure of making and look forward to many more.

The team at FORE wishes you happy holidays, and best wishes for a wonderful new year!

Richard Schottenfeld, M.D., a Pioneer in Bringing Addiction Treatment to Underserved Communities, Joins FORE’s Board of Directors December 20, 2019

We are pleased to welcome Richard Schottenfeld, M.D., professor and chair of the Department of Psychiatry and Behavioral Sciences at Howard University College of Medicine, to FORE’s Board of Directors. Schottenfeld is an innovator in the field of addiction medicine and the integration of treatment for substance use and other psychiatric disorders in primary care settings.

“Dr. Schottenfeld brings a unique combination of academic rigor and hands-on experience,” says Andrea Barthwell, M.D., FORE’s board chair, the founder and CEO of Two Dreams, and medical director at Encounter Medical Group. “From his early experience as a general practitioner in rural Wyoming to his current efforts to bring treatment and recovery services into urban, community-based settings, he has consistently responded to the needs of patients and found practical ways to help. The urban primary care clinic he directed served as a model for integrating substance use treatment to primary care.”

Schottenfeld also led some of the early studies of medication-assisted treatments for opioid use disorder in primary care clinics and physicians’ offices. His studies of buprenorphine helped lead to approval in the U.S. of buprenorphine for treatment of opioid use disorder outside of specialized narcotic treatment programs.

“The thrust of my career has been to make substance use disorder treatment more readily available to more people,” says Schottenfeld. “I am thrilled to be joining FORE’s efforts to identify what’s working and spread innovative models around the nation.”

As a leading clinical researcher and educator, Schottenfeld has authored more than 125 peer-reviewed publications, directed training programs in addiction psychiatry, and led post-doctoral drug abuse clinical research. He also created an interdisciplinary faculty development program that has produced a cadre of faculty in internal medicine, obstetrics and gynecology, pediatrics, and psychiatry leading to the development of substance use disorders training, clinical services, and research in their departments.

Schottenfeld earned a B.A. from Yale College, graduating Phi Beta Kappa, magna cum laude, and with distinction in English literature. After earning an M.D. degree from Yale, he completed an internship in internal medicine at the Mt. Sinai Hospital in New York City before working for a year as a general practitioner in Hanna and Green River, Wyoming. He returned to Yale to complete psychiatry residency training and a Robert Wood Johnson Clinical Scholars Program clinical research fellowship.

President’s Update, Nov. ’19: Lessons from FORE’s First RFP Process November 25, 2019

In this season of giving thanks, I wanted to express my sincere appreciation to the many of you who submitted proposals during FORE’s first-ever request-for-proposal (RFP) process. We received more than 440 responses from organizations in 46 states, representing those working in academia, nonprofits, public charities, government agencies, health systems, and federally qualified health centers. As we hoped, the proposed projects further FORE’s four overarching goals:

  • Educating providers about opioid use disorder (OUD) prevention and treatment
  • Expanding and sustaining evidence-based treatment and payment approaches
  • Informing state and federal policies
  • Raising public awareness of effective strategies to curtail the opioid epidemic

The volume of proposals vastly exceeded our expectations and has made the process highly competitive. In this initial round, we invited full grant proposals from about 20 percent of the organizations that submitted letters of intent. We will announce our first grant awards by the end of January. In the meantime, I want to share a few of our observations so far.

Even with public dollars and other resources, there is still substantial room for a small foundation to help. We were heartened to hear about the incredible work taking place in communities around the country and have gained a clearer understanding of how we might help. At the same time, we realized some applicants may be unaware of the availability of state and federal funding for their efforts. It seems clear that government leaders can do more to raise awareness when there are state and federal grants for certain direct services, such as telehealth-based treatment or naloxone supplies. It may also help if we share information with other funders about unmet needs identified during the RFP process.

There is a pressing need to build the nation’s behavioral health infrastructure. The proposals laid bare the fact that behavioral health services were few and far between in many parts of the country well before the opioid crisis increased demand. Today, psychiatrists, primary care providers, and other prescribers as well as counselors, coaches, and other professionals are struggling to deliver OUD treatment to all in need. These professionals need training opportunities and ongoing support.

Several efforts target vulnerable populations. We received proposals from people working in rural, urban, Native American, and other communities where people may be particularly vulnerable because they have low incomes, poor health, and/or limited access to care. The populations they serve are diverse, from pregnant women and mothers trying to juggle treatment with parenting to people just released from jails and prisons who are at high risk of relapse, overdose, and death. Our goal is to ensure that all those in need are served.

More clarity on FORE’s funding priorities is needed. We received nearly 200 responses to our survey asking for feedback on the RFP process. The most common suggestion was to offer more details about what we do and do not fund. Our first round of grants will do just that by enabling us to share concrete examples.

We are thankful to all those who have taken the time to submit proposals. In early 2020, we will continue to fund new opportunities and we hope you remain part of our network. The work of each and every one of you is vital to ending the opioid crisis.

(Picture: FORE’s inaugural RFP elicited proposals from over 440 organization from 46 states.)

President’s Update, Oct. ’19: Once the Epicenter of the Opioid Crisis, Huntington, WV, Is Focusing on Solutions October 30, 2019

Earlier this month, my staff and I visited Huntington, W.V., a city that made headlines in 2016 after 26 residents overdosed in a four-hour period. Leaders of this small Appalachian city bordering Kentucky and Ohio have strived to understand the problem by working with researchers to identify the rates and types of injection drug use, the demographics of those affected, and the problems they face. Now the city is emerging as a leader in finding and implementing solutions. During our visit, we saw how city leaders and their community partners have rallied around residents suffering from opioid use disorder by promoting harm reduction and increasing access to treatment.

For example, in December 2017, the city established a Quick Response Team (QRT) through their Cabell County Emergency Medical Services. The QRT includes a paramedic, a peer recovery coach, a clergy member, and a police officer. Team members reach out within 72 hours and often sooner to residents whose opioid overdoses were reversed when paramedics administered naloxone. They encourage people to seek treatment or promote harm-reduction strategies for those who are not yet ready to do so—visiting multiple times in efforts to persuade people they care about their recovery. The approach is modeled on a program in Colerain Township, a suburb of Cincinnati, Ohio, and was launched with $1.35 million in federal grants. Team members’ persistence and resourcefulness have been remarkable. Not only will they search for available beds in treatment facilities and help people enroll in Medicaid coverage, they’ve even driven some to other states for care. Their knowledge of and presence in the local community contributes to their success: they’ve reached about half of those identified through the emergency medical response system or referrals from concerned family and friends and connected roughly a third of those with treatment.

We also visited PROACT (Provider Response Organization for Addiction Care and Treatment), a nonprofit organization offering medication-based treatment, therapy, education, job training, and other support services within the Valley Health federally qualified health center. It also includes a pharmacy and play space for children whose parents are receiving services and offers group and spiritual counseling. PROACT was developed by local health care providers who came together to fill gaps in local services and collectively finance them.

Community leaders are also thinking about the supports people need during the vulnerable period following initial treatment. Last year, Huntington City Mission, Marshall University Joan C. Edwards School of Medicine, and Marshall Health launched Project Hope for Women and Children, a transitional living facility for new and expectant mothers that provides peer and residential support, life skills training, and mental health services. It can house women and their children for up to six months, allowing them to continue in treatment and receive counseling and job training services.

Finally, we had the opportunity to meet with local foundations, including our host organization, The Pallottine Foundation, that have supported these and other efforts and are now working to spread lessons across West Virginia and beyond. They are also focusing on what Huntington needs to sustain current initiatives and build a healthier community for the future. One strategy for doing so is placing social workers in elementary schools, where they offer support to children living with parents or other adults struggling with addiction.

The visit to Huntington serves as an important reminder of why we do this work and suggests that a having a vision for a better future, collaboration, commitment, and compassion are key ingredients in efforts to curtail the opioid crisis. We also witnessed the value of projects that are embedded in the community and reflect local values, culture, and leadership. The city has seen a 25 percent decline in overdose death rates since this work got underway.

(Picture: The Quick Response Team—which includes Larrecsa Cox, a paramedic with Cabell County Emergency Medical Services; Virgil Johnson, a faith leader; and Sue Howland, a peer recovery coach with Prestera Center—has been known to make as many as eight attempts to reach someone.)

President’s Update, Sep. ’19: Learning from Those on the Front Lines September 30, 2019

Over the past few months, my colleagues and I have visited several states that have been hard hit by the opioid epidemic — among them Maine, North Carolina, Ohio, and Pennsylvania — so we could hear from those developing innovative solutions. We learned a lot and wanted to share some of our insights.

We can leverage the strengths of people with lived experience.

In Maine, where I attended Governor Janet Mills’ Opioid Response Summit, I saw how important it is to engage people directly affected by the opioid epidemic. Each session was launched by a person in recovery or a family member. One of the most memorable sessions was led by a young man who spoke about the obstacles he overcame to find treatment—not just for his addiction, but also for other serious health problems. His story illustrates the value of models that integrate primary care, behavioral health care, and addiction treatment. Understanding patient experiences is essential to refining our treatment approaches and tailoring services to the needs of different groups.

Those who have successfully navigated treatment for opioid use disorder (OUD) can also engage others. In Ohio, we met peer recovery coaches at Ohio State University’s (OSU) Wexner Medical Center. The coaches forge relationships with people arriving in the ED after an overdose in an attempt to engage them in treatment. This itself is a sign of progress: ED physicians told us a year ago they mostly revived people from overdoses; with the spread of naloxone, physicians are now more likely to see people who’ve already been revived and may be ready for longer-term help. Peer coaches are key to establishing trust, OSU’s physicians and nurses told us, because their lived experience demonstrates recovery is possible, even if people aren’t yet ready to accept help.

We must take a holistic approach to OUD treatment.

We also observed two programs for pregnant women coping with OUD. OSU’s medical center hosts a comprehensive program for pregnant women with OUD. In addition to taking part in group prenatal sessions, women receive medication-based treatment (MBT) and counseling from a team that includes a maternal/fetal medicine specialist, an addiction medicine fellow, and peer recovery coaches.

The Horizons program at the University of North Carolina (UNC) offers a similarly holistic package. The residential and outpatient program for pregnant women offers prenatal care, MBT, counseling, and supportive services. Some women stay for as long as a year, receiving well-child care as well as job and parenting training.

Programs that offer holistic treatment and wraparound supports help women deliver healthy babies and rebuild their lives. Horizons also provides a model for other health care programs on how to leverage diverse funding streams to support women for up to a year.

We need to support people during vulnerable transitions.

Our visits demonstrated how important it is to offer support over time — especially during moments when people may be most vulnerable. At OSU’s medical center, leaders try to connect women with other sources of treatment after the six-week postpartum period, but they worry they will struggle without having integrated medical, behavioral health, and social supports.

At the University of Pittsburgh Medical Center (UPMC) and elsewhere, teams are working to create strong guardrails to steer people from the ED to ongoing treatment. UPMC’s addiction consults team comes to the ED to assess overdose patients and recommend treatment plans.

Thank you to our hosts who so generously shared their experiences. We need to learn from organizations like these about how best to support people making transitions from one treatment setting to another, or through different stages of recovery.

In future President’s Updates, I’ll share lessons from our upcoming visits to West Virginia and other states.

(Picture: FORE president Karen A. Scott, M.D., M.P.H., meets the thriving two-month-old son of a Horizons participant, who is benefiting from the program’s array of addiction treatment and social supports.)

Update and Survey on ‘Access to Treatment’ Request for Proposal September 3, 2019

After receiving an overwhelming response to the RFP, we are asking for your feedback!

We had a tremendous response to FORE’s inaugural Request for Proposal (RFP) and are looking forward to developing a strong network of grantees, partners, and collaborators. Applicants who submitted a Letter of Intent by the deadline can expect a confirmation of receipt email by the end of the week.

Over the next few weeks, we will be reviewing all the submissions. In the meantime, we would love to get some feedback on your experience with the process so far. You can help us improve, whether or not you submitted an application, by completing our brief anonymous survey.

Click here to complete the survey.

We thank you for all your efforts of furthering our collective goal of bringing an end to the opioid crisis.

FORE’s President Speaks with Addiction Professional August 6, 2019

Dr. Karen Scott speaks about FORE’s unique opportunity as a private foundation

On August 6th, 2019, the Foundation for Opioid Response Efforts (FORE) President Dr. Karen Scott spoke with Gary A. Enos, Editor at Addiction Professional. Dr. Scott outlined her journey since joining FORE and how she approached building the Foundation’s infrastructure. With a focus on the FORE’s first Request for Proposal (RFP), Dr. Scott expressed the Foundation’s goal of supporting organizations that can connect underserved and vulnerable populations to evidence-based opioid use treatment and recovery services.

You can find the full article at Addiction Professional.

FORE Holds Webinar Introducing the Foundation and the Inaugural RFP August 1, 2019

In conjunction with the release of the inaugural RFP, FORE held an open webinar to introduce the Foundation and provide information and respond to questions regarding the inaugural ‘Access to Treatment’ RFP.

On August 1, 2019, the Foundation for Opioid Response Efforts (FORE) held a webinar to provide information regarding the Foundation and to respond to questions related to the recently released “Improving Access to Opioid Use Disorder Treatment and Recovery Services for Underserved Populations and Communities” Request for Proposal (RFP).

FORE President Dr. Karen Scott began by giving an introduction about the Foundation’s origins and vision: To inspire and accelerate action to end the opioid epidemic. Dr. Scott also discussed what FORE’s approach to developing programs, partnerships, and grantmaking will be as the Foundation continues to grow. FORE Senior Program Officer Dr. Ken Shatzkes then spent time going over how the Foundation developed the inaugural ‘Access to Treatment’ RFP. The RFP was heavily informed by expert Program Advisory meetings that FORE convened in early 2019. Dr. Shatzkes covered many topics related to the RFP, including target projects the Foundation is interested in, eligibility guidelines, as well as FORE’s grant selection process. The second part of the webinar included a 30-minute Q&A session where participants were able to ask a wide variety of questions.

There was an overwhelming response to the webinar, as registration reached maximum capacity. Of 520 registered participants, over 430 people representing 45 different States attended the webinar. The slide deck, recorded webinar, and an FAQ are now available online for viewing.

FORE Releases Inaugural Request for Proposal July 17, 2019

The Foundation’s first RFP is focused on improving access to appropriate opioid use disorder treatment and recovery services for underserved and vulnerable populations.

The Foundation for Opioid Response Efforts (FORE) is proud to release the Foundation’s inaugural request for proposal (RFP): “Improving Access to Opioid Use Disorder Treatment and Recovery Services for Underserved Populations and Communities.” The purpose of this RFP is to help providers and communities develop ways to treat their most vulnerable and underserved populations with OUD by creating and/or evaluating innovative programs and policy proposals that improve access to a continuum of care of appropriate addiction treatment, including wraparound and recovery supportive services, or that expand upon existing promising models.

As a national foundation, FORE is committed to funding a diverse cohort of projects across the United States. Competitive applications will demonstrate innovative and creative ways to remove barriers to OUD treatment and recovery services for underserved populations that could credibly demonstrate the potential to be scaled to a national level to reach the largest number of patients and have the greatest impact.

Applicants may request up to $300,000 annually for up to two years. All applications must be submitted by email to AccessRFP@ForeFdn.org by 11:59 PM EST on August 25, 2019.

For more information, please download the RFP documents here.

FORE President is a Featured Panelist at the 7th Annual Public-Private Collaborations in Rural Health Meeting May 30, 2019

Dr. Karen Scott joined other prominent experts in the field on a panel to discuss rural lessons learned from the opioid crisis. Dr. Scott introduced the foundation and discussed the importance of collaboration to support best practices making an impact in these communities.

On May 30, 2019, Foundation for Opioid Response Efforts (FORE) President Dr. Karen Scott participated on a panel focused on “Early Lessons Learned from the Opioid Epidemic” at the 7th annual Public-Private Collaborations in Rural Health Meeting, co-hosted by the Federal Office of Rural Health Policy at the Health Resources and Services Administration (HRSA), Grantmakers in Health (GIH), and the National Rural Health Association. Along with co-panelists from two federal agencies – HRSA and the White House Office of National Drug Control Policy (ONDCP) – and a regional foundation funding projects in West Virginia, – the Claude Worthington Benedum Foundation – Dr. Scott had the opportunity to introduce FORE, provide some background on issues of importance to the foundation, and describe the foundation’s early activities responding to challenges facing rural communities across the country.

The impact of the opioid crisis on rural communities is well documented. Disparities in access to healthcare, along with social and economic depression, is reflected in data which show both the high mortality rates from opioid overdoses and low rates of treatment. Federal agencies are working to target funding to these much-needed areas. In addition, the panel discussed ways in which private foundations have and can contribute to addressing local challenges – through support for specific projects, as well as partnering with public agencies and other foundations. This was an important opportunity for FORE to introduce our planned Request for Proposal on ‘Access to Treatment’ and connect with many local funders and federal agency leads.

Rx Drug Abuse & Heroin Summit Webinar Highlights FORE’s Approach to the Crisis May 15, 2019

FORE Board Chair Dr. Andrea Barthwell’s webinar focused on the need to identify new approaches and enhance and expand existing policies and programs proven to reduce opioid use disorder, addiction, and overdose.

The fast-evolving nature of the U.S. prescription opioid, heroin, and illicit fentanyl crisis can make it difficult to stay on top of timely issues and opportunities to make a greater impact. During the webinar, FORE Board Chair Dr. Andrea Barthwell, former President of the American Society of Addiction Medicine (ASAM) and Deputy Director for Demand Reduction in the White House Office of National Drug Control Policy (ONDCP) under President George W. Bush, introduced the Foundation of Opioid Response Efforts (FORE). She provided a concise overview of the opioid crisis based on her thirty years of experience in addiction medicine and shared how FORE plans to take action to address this public health challenge.

Dr. Barthwell shared FORE’s mission: To convene and support partners advancing patient-centered, evidence-based solutions addressing the opioid crisis. She described FORE’s intention to inspire and advance activities to address this public health emergency. With patients at the center, FORE’s areas of focus include provider education, payer strategies, policy Initiatives, and public awareness. Dr. Barthwell also announced that FORE will be convening advisory meeting panels with leading experts and stakeholders to advise Foundation staff on what is currently being done and where the greatest needs are. The panels will heavily inform a Request for Proposal (RFP) that FORE will be releasing later in the year.

(Picture: FORE Board of Directors Chair Andrea Barthwell, M.D., DFASAM, with U.S. Congressman Hal Rogers (R-KY, 5th District) and Michael Barnes, Esq., Managing Partner and Founder of DCBA Law & Policy.)